Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?
Iezzi R, Pompili M, Posa A, Carchesio F, Siciliano M, Annicchiarico BE, Agnes S, Giuliante F, Garcovich M, Cerrito L, Ponziani FR, Basso M, Cassano A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Manfredi R; HepatoCATT Study Group for the Multidisciplinary Management of HCC. Iezzi R, et al. Among authors: cerrito l. Eur J Radiol. 2019 May;114:32-37. doi: 10.1016/j.ejrad.2019.02.030. Epub 2019 Feb 23. Eur J Radiol. 2019. PMID: 31005173
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1).
Iezzi R, Casà C, Posa A, Cornacchione P, Carchesio F, Boldrini L, Tanzilli A, Cerrito L, Fionda B, Longo V, Miele L, Lancellotta V, Cellini F, Tran HE, Ponziani FR, Giuliante F, Rapaccini GL, Grieco A, Pompili M, Gasbarrini A, Valentini V, Gambacorta MA, Tagliaferri L, Manfredi R. Iezzi R, et al. Among authors: cerrito l. Eur Rev Med Pharmacol Sci. 2022 Apr;26(8):2891-2899. doi: 10.26355/eurrev_202204_28620. Eur Rev Med Pharmacol Sci. 2022. PMID: 35503635 Free article.
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
Iezzi R, Pompili M, Rinninella E, Annicchiarico E, Garcovich M, Cerrito L, Ponziani F, De Gaetano A, Siciliano M, Basso M, Zocco MA, Rapaccini G, Posa A, Carchesio F, Biolato M, Giuliante F, Gasbarrini A, Manfredi R; HepatoCatt Study Group. Iezzi R, et al. Among authors: cerrito l. Eur Radiol. 2019 Mar;29(3):1285-1292. doi: 10.1007/s00330-018-5692-8. Epub 2018 Aug 31. Eur Radiol. 2019. PMID: 30171360
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.
De Gaetano AM, Catalano M, Pompili M, Marini MG, Rodríguez Carnero P, Gullì C, Infante A, Iezzi R, Ponziani FR, Cerrito L, Marrone G, Giuliante F, Ardito F, Rapaccini GL, Vecchio FM, Giraldi L, Manfredi R; HEPATOCATT STUDY GROUP. De Gaetano AM, et al. Among authors: cerrito l. Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7786-7801. doi: 10.26355/eurrev_201909_18988. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599447 Free article.
Regorafenib: a promising treatment for hepatocellular carcinoma.
Cerrito L, Ponziani FR, Garcovich M, Tortora A, Annicchiarico BE, Pompili M, Siciliano M, Gasbarrini A. Cerrito L, et al. Expert Opin Pharmacother. 2018 Dec;19(17):1941-1948. doi: 10.1080/14656566.2018.1534956. Epub 2018 Oct 20. Expert Opin Pharmacother. 2018. PMID: 30345837 Review.
Advances in pharmacotherapeutics for hepatocellular carcinoma.
Cerrito L, Santopaolo F, Monti F, Pompili M, Gasbarrini A, Ponziani FR. Cerrito L, et al. Expert Opin Pharmacother. 2021 Jul;22(10):1343-1354. doi: 10.1080/14656566.2021.1892074. Epub 2021 Mar 3. Expert Opin Pharmacother. 2021. PMID: 33637024
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma.
Maestri M, Pallozzi M, Santopaolo F, Cerrito L, Pompili M, Gasbarrini A, Ponziani FR. Maestri M, et al. Among authors: cerrito l. Expert Opin Investig Drugs. 2022 Apr;31(4):347-360. doi: 10.1080/13543784.2022.2033208. Epub 2022 Feb 9. Expert Opin Investig Drugs. 2022. PMID: 35072571
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.
Ponziani FR, Spinelli I, Rinninella E, Cerrito L, Saviano A, Avolio AW, Basso M, Miele L, Riccardi L, Zocco MA, Annicchiarico BE, Garcovich M, Biolato M, Marrone G, De Gaetano AM, Iezzi R, Giuliante F, Vecchio FM, Agnes S, Addolorato G, Siciliano M, Rapaccini GL, Grieco A, Gasbarrini A, Pompili M. Ponziani FR, et al. Among authors: cerrito l. World J Hepatol. 2017 Dec 28;9(36):1322-1331. doi: 10.4254/wjh.v9.i36.1322. World J Hepatol. 2017. PMID: 29359015 Free PMC article.
537 results